{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "RNA genome",
      "RNA motif",
      "RNA secondary structure",
      "RNA structure",
      "RNA virus",
      "SHAPE-MaP",
      "chemical probing",
      "coronavirus",
      "locked nucleic acids",
      "riboregulation"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33444546",
  "DateCompleted": {
    "Year": "2021",
    "Month": "02",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.molcel.2020.12.041",
      "S1097-2765(20)30962-X"
    ],
    "Journal": {
      "ISSN": "1097-4164",
      "JournalIssue": {
        "Volume": "81",
        "Issue": "3",
        "PubDate": {
          "Year": "2021",
          "Month": "Feb",
          "Day": "04"
        }
      },
      "Title": "Molecular cell",
      "ISOAbbreviation": "Mol Cell"
    },
    "ArticleTitle": "Comprehensive in\u00a0vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.",
    "Pagination": {
      "StartPage": "584",
      "EndPage": "598.e5",
      "MedlinePgn": "584-598.e5"
    },
    "Abstract": {
      "AbstractText": [
        "Severe-acute-respiratory-syndrome-related coronavirus 2 (SARS-CoV-2) is the positive-sense RNA virus that causes coronavirus disease 2019 (COVID-19). The genome of SARS-CoV-2 is unique among viral RNAs in its vast potential to form RNA structures, yet as much as 97% of its 30 kilobases have not been structurally explored. Here, we apply a novel long amplicon strategy to determine the secondary structure of the SARS-CoV-2 RNA genome at single-nucleotide resolution in infected cells. Our in-depth structural analysis reveals networks of well-folded RNA structures throughout Orf1ab and reveals aspects of SARS-CoV-2 genome architecture that distinguish it from other RNA viruses. Evolutionary analysis shows that several features of the SARS-CoV-2 genomic structure are conserved across \u03b2-coronaviruses, and we pinpoint regions of well-folded RNA structure that merit downstream functional analysis. The native, secondary structure of SARS-CoV-2 presented here is a roadmap that will facilitate focused studies on the viral life cycle, facilitate primer design, and guide the identification of RNA drug targets against COVID-19."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA."
          }
        ],
        "LastName": "Huston",
        "ForeName": "Nicholas C",
        "Initials": "NC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA."
          }
        ],
        "LastName": "Wan",
        "ForeName": "Han",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA."
          }
        ],
        "LastName": "Strine",
        "ForeName": "Madison S",
        "Initials": "MS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemistry, Yale University, New Haven, CT 06511, USA."
          }
        ],
        "LastName": "de Cesaris Araujo Tavares",
        "ForeName": "Rafael",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510, USA; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA."
          }
        ],
        "LastName": "Wilen",
        "ForeName": "Craig B",
        "Initials": "CB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA; Department of Chemistry, Yale University, New Haven, CT 06511, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: anna.pyle@yale.edu."
          }
        ],
        "LastName": "Pyle",
        "ForeName": "Anna Marie",
        "Initials": "AM"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 HG009622",
        "Acronym": "HG",
        "Agency": "NHGRI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "T32 AI007019",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "T32 AI055403",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "DGE1752134",
        "Agency": "National Science Foundation",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Mol Cell",
    "NlmUniqueID": "9802571",
    "ISSNLinking": "1097-2765"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "bioRxiv. 2020 Jul 10;:",
      "PMID": "32676598"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nucleic Acid Conformation"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Response Elements"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "Declaration of interests A patent application on MarathonRT has been filed by Yale University."
}